Physician profile
John Chandler
NPI 1740262419
$1,857.36
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $231 · 2021: $30.62 · 2022: $166 · 2023: $43.43 · 2024: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $276.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $179.88 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $162.34 | 2019-2020 | |
| Amarin Pharma, INC. | $158.76 | 2019-2020 | |
| Abbott Laboratories | $156.36 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $138.08 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $124.79 | 2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $110.69 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $99.75 | 2019-2023 | Farxiga |
| Pfizer INC. | $68.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.22 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $61.53 | 2019-2024 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $53.99 | 2019 | |
| Esperion Therapeutics, INC. | $47.12 | 2021-2024 | Nexletol |
| Inspire Medical Systems, INC. | $32.30 | 2024 | Inspire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $27.90 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $25.16 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.53 | 2019 | |
| Cvrx, INC. | $18.79 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.83 | 2019 | |
| Allergan, INC. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.